SAN DIEGO, Feb. 25 /PRNewswire/ — Imagenetix, Inc. (OTC Bulletin Board: IAGX – News), announced today that the International Federation of Sports Medicine (FIMS) and its Executive Committee has selected Celadrin® Topical Cream as its Official Pain Relieving Cream. FIMS’s goal since 1928 was to provide the best medical care for the athletes of the [...]

{ Comments on this entry are closed }

SAN DIEGO, Oct. 9 /PRNewswire-FirstCall/ — Imagenetix, Inc. (OTC Bulletin Board: IAGX – News), announced today the appointment of Dr. Thomas Van Dyke to its Medical Advisory Board. Dr. Van Dyke will provide guidance to Imagenetix on their experimental compound, 1-TDC, for the treatment and prevention of periodontal disease. Dr. Van Dyke is Professor, Department [...]

{ Comments on this entry are closed }

Expects To See Substantial Sales Growth Balance of Year
SAN DIEGO, Aug. 17 /PRNewswire-FirstCall/ — Imagenetix, Inc. (OTC Bulletin Board: IAGX – News), will present at the Noble Financial Equity Conference at 11:30 a.m. EDT on Tuesday, August 21, 2007 at the Charleston Place Hotel in Charleston, South Carolina.
William Spencer, Imagenetix’s Chief Executive Officer will [...]

{ Comments on this entry are closed }

Imagenetix Inc. Reports First Quarter Results

by Imagenetix on August 14, 2007

Net Sales Increase 21%
Gross Margins Improve 6%
EPS $(0.04) verse $(0.04)
Sees Significant Growth in Sales for Balance of Year

SAN DIEGO, Calif., Aug. 14 /PRNewswire-FirstCall/ — Imagenetix, Inc. (OTC Bulletin Board: IAGX – News), today reported results for its first fiscal quarter ended June 30, 2007. Net sales increased 21% to $1,126,991 from the $931,569 reported for [...]

{ Comments on this entry are closed }

Fourth Quarter Revenues Increases More Than 120% From Prior Year
Fourth Quarter Net Income Before Tax $107,000 Versus Loss of $990,000 in Same Period Last Year
Sees Solid Gains in Sales and Profits in Fiscal 2008

SAN DIEGO, June 28 /PRNewswire-FirstCall/ — Imagenetix, Inc. (OTC Bulletin Board: IAGX – News), announced today results for its fourth fiscal quarter [...]

{ Comments on this entry are closed }